MedWatch

The Lundbeck Foundation's new strategy: CEO wants to buy more firms like Lundbeck, ALK and Falck

The Lundbeck Foundation launches new ten-year plan with central wish to acquire major owner's shares in up to five new enterprises.

The Lundbeck Foundation CEO Lene Skole. | Photo: Gregers Tycho/Ritzau Scanpix

The highly affluent Lundbeck Foundation turns up its level of ambition and gets ready to place  some of the fund's fortune in worthy companies.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs